![]() |
Volumn 46, Issue 3, 2000, Pages 246-250
|
Preclinical oral antitumor activity of BMS-185660, a paclitaxel derivative
a
|
Author keywords
Anticancer drugs; Taxane; Taxol
|
Indexed keywords
BMS 181681;
BMS 185660;
TAXOL;
TAXOL DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER MODEL;
COLON CARCINOMA;
DRUG EFFECT;
DRUG SCREENING;
HUMAN;
HUMAN CELL;
LUNG CARCINOMA;
MALIGNANT NEOPLASTIC DISEASE;
MOUSE;
NONHUMAN;
NUDE MOUSE;
OVARY CARCINOMA;
PRIORITY JOURNAL;
ADMINISTRATION, ORAL;
ANIMAL;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
COLONIC NEOPLASMS;
COMPARATIVE STUDY;
DRUG SCREENING ASSAYS, ANTITUMOR;
FEMALE;
HUMAN;
INJECTIONS, INTRAVENOUS;
INJECTIONS, SUBCUTANEOUS;
LUNG NEOPLASMS;
MICE;
MICE, INBRED BALB C;
MICE, INBRED DBA;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
OVARIAN NEOPLASMS;
PACLITAXEL;
|
EID: 0033797809
PISSN: 03445704
EISSN: None
Source Type: Journal
DOI: 10.1007/s002800000137 Document Type: Article |
Times cited : (14)
|
References (13)
|